Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial.
Frater J. et al, (2021), Lancet HIV, 8, e474 - e485
CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotype.
Thornhill JP. et al, (2019), Mucosal Immunol, 12, 1212 - 1219
Development of a Simple In Vitro Assay to Assess Digestion of the Extracellular Matrix of the Human Pancreas by Collagenase Enzyme Blends.
Spiers RM. et al, (2018), Cell Transplant, 27, 1039 - 1046
CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA.
Martin GE. et al, (2018), Front Immunol, 9
Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection.
Hoffmann M. et al, (2016), PLoS Pathog, 12
HIV-1 DNA predicts disease progression and post-treatment virological control.
Williams JP. et al, (2014), Elife, 3
HIV-1-specific CD4(+) responses in primary HIV-1 infection predict disease progression.
Frater J. et al, (2014), AIDS, 28, 699 - 708
Longitudinal analysis of an HLA-B*51-restricted epitope in integrase reveals immune escape in early HIV-1 infection.
Yager N. et al, (2013), AIDS, 27, 313 - 323
Failure to detect xenotropic murine leukemia virus-related virus in blood of individuals at high risk of blood-borne viral infections.
Barnes E. et al, (2010), J Infect Dis, 202, 1482 - 1485
Prevalence of HIV type-1 drug-associated mutations in pre-therapy patients in the Free State, South Africa.
Huang K-HG. et al, (2009), Antivir Ther, 14, 975 - 984
Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression.
Frater AJ. et al, (2007), J Virol, 81, 6742 - 6751
CD8+ T cell epitope-flanking mutations disrupt proteasomal processing of HIV-1 Nef.
Milicic A. et al, (2005), J Immunol, 175, 4618 - 4626
HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound
Scriba TJ. et al, (2005), Journal of Clinical Investigation, 115, 443 - 450
HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound.
Scriba TJ. et al, (2005), J Clin Invest, 115, 443 - 450